U.S. Blood Warmers Market (2025 - 2033) Size, Share & Trends Analysis Report By Type (Hardware & Consumables), By Flow Rate, By Application, By End Use, And Segment Forecasts

U.S. Blood Warmers Market Summary

The U.S. blood warmer market size was estimated at USD 76.2 million in 2024 and is projected to reach USD 146.8 million by 2033, growing at a CAGR of 7.6% from 2025 to 2033. This market is driven by the rising number of surgical procedures and trauma cases requiring rapid blood transfusions under controlled temperatures to prevent rising cases of cold-weather injuries, such as hypothermia and related complications.

The U.S. blood warmer market is experiencing steady growth, fuelled by many surgeries, trauma cases, and emergency care situations requiring blood and fluid transfusions at normothermic temperatures. According to the report published by the Brain Injury Association of America, in March 2024, approximately 2.8 million Americans were suffering from traumatic brain injury, and approximately 5 million people have a permanent disability due to brain injury, which is one in 60 Americans. 

Another major driver is the growing demand for portable and pre-hospital blood warmers. EMS providers across states are increasingly adopting compact, battery-powered devices for field use. The EMS department updated its emergency protocols to include blood warmers in ambulances to better manage hypovolemic shock and improve survival rates in critical situations. In August 2024, the Delta Development Team, launched the Single Unit Blood Warmer (SUBW), a cutting-edge addition to their lineup of prehospital blood delivery devices. The product is specifically optimized for arctic conditions, where freezing temperatures can create significant challenges.

Moreover, government authorities' stringent regulatory standards and supportive initiatives are expected to boost the demand for blood warmers the nation. For instance, in June 2023, ICU Medical. Inc. announced the launch of the Level 1 H-1200 Fast Flow Fluid Blood Warmer, a device used for blood and fluid warming and other solutions in hospital facilities. The product is also used when patients have undergone blood loss or are at risk of hypothermia after surgery and are undergoing urological irrigation.

Market Concentration & Characteristics

The U.S. blood warmer market is growing at an accelerating pace. It is moderately concentrated, with a significant number of players. The market is structured for applications such as trauma care, surgery, and emergency medical response, resulting in a preference for brands with proven safety, performance, and compliance history.

Manufacturers focus on improving flow rates, reducing warm-up time, and enhancing mobility without compromising safety. The market has witnessed increased innovation in rugged, lightweight designs for field hospitals and air ambulances, driven by military and pre-hospital care needs.

Regulatory impact is high; all blood warmers must be FDA 510(k)-cleared medical devices. Additionally, compliance with hospital accreditation standards (e.g., The Joint Commission) and temperature management guidelines from professional bodies (e.g., ASA) shapes procurement and usage patterns.

Product substitutes have a low impact in critical applications, as warming devices are the standard of care in surgical and emergency transfusions. While warming blankets or room-temperature fluids may be used in non-critical cases, they cannot replace the precision and speed of modern blood warmers in trauma or surgical situations.

Type Insights

The hardware segment held the largest revenue share of 72.4% in 2024. This dominance is largely attributed to the widespread deployment of warming systems in operating rooms, ICUs, ambulances, and military field units. Hospitals and trauma centers increasingly prioritize devices with rapid heating capacity, integrated safety features, and compliance with FDA and Joint Commission standards. A noticeable trend is the surge in demand for portable and battery-operated models, especially in pre-hospital and point-of-care settings. As per Belmont Medical Technologies, the Belmont Rapid Infuser RI-2 is a blood warmer and rapid infuser that enables the fast and reliable delivery of life-saving blood and IV fluids to combat hypothermia and blood loss in adult and pediatric patients.

The consumables segment is projected to grow at the fastest CAGR of 8.2% from 2025 to 2033, driven by the recurring need for disposable cartridges, tubing sets, and warming sleeves associated with each procedure.

Flow Rate Insights

The rapid/fast flow warmers segment held the largest revenue share in 2024, primarily due to its critical application in high-acuity environments such as trauma centers, emergency departments, and operating rooms. These warmers can deliver large volumes of blood or fluids rapidly, making them indispensable during massive transfusion protocols (MTPs). Hospitals in major U.S. cities with Level I trauma centers, such as New York-Presbyterian and Cedars-Sinai, have widely adopted fast flow systems,

The routine/standard flow warmers segment is projected to grow at the fastest CAGR from 2025 to 2030. These systems are designed to provide consistent warming at moderate flow rates, making them ideal for regular transfusions, pediatric care, and scheduled procedures. A growing emphasis on cost-efficiency and infection control pushes facilities to opt for simpler, low-maintenance devices.

Application Insights

The surgery segment held the largest market share in 2024, driven by the widespread use of blood warmers in various surgical procedures, particularly those involving large blood loss, such as orthopedic, cardiac, and transplant surgeries. Blood warmers are essential for maintaining normothermia during operations, helping reduce intraoperative complications, and improving recovery outcomes.

The acute care segment is expected to grow at the fastest CAGR of 8.9% in the coming years, driven by the widespread use of blood warmers in trauma care, massive transfusions, surgical procedures, emergency cases, and vulnerable patients. The acute market segment is primarily driven by the growing number of transfusion cases nationwide. For instance, according to the American Red Cross report published in 2025, every 2 seconds, someone in the U.S. needs blood or platelets. In addition, approximately 29,000 units of red blood cells are required in the U.S. almost every day. Moreover, the U.S. Centers for Medicare & Medicaid Services (CMS) has pushed for enhanced emergency preparedness standards, prompting hospitals to invest in robust acute care warming infrastructure.

End Use Insights

The hospitals/clinics segment held the market share in 2024 and is projected to grow at the fastest CAGR during the forecast period. This dominance is driven by the high volume of surgical procedures, trauma care, and emergency interventions in hospital settings that demand precise thermal management. Hospitals are heavily investing in rapid and routine blood warming systems integrated into their surgical suites, emergency departments, and ICUs to comply with patient safety protocols.

The defense forces segment is projected to grow rapidly over the forecast period, driven by increasing military investments in battlefield trauma care and pre-hospital stabilization technologies. As geopolitical instability increases the demand for field medical preparedness, defense-driven innovations are also expected to influence broader commercial market developments.

Key U.S. Blood Warmer Company Insights

Some key players operating in the market include GENTHERM, Belmont Medical Technologies, 3M, and others.

• Belmont is known for its Rapid Infuser RI-2, which is widely used in hospitals and trauma centers for high-volume, fast-flow transfusions. The company continues to expand its product line with advanced features such as closed-loop temperature control and EMR integration, and systems are also favored under massive transfusion protocols (MTPs) in Level I trauma facilities.

Recent Developments

• In August 2024, the Delta Development Team announced the launch of innovative system for prehospital blood delivery devices, the Single Unit Blood Warmer (SUBW). The product would transform blood warming technology across military, rural emergency response teams.

U.S. Blood Warmers Market Report Scope

U.S. Blood Warmers Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. blood warmers market report based on type, flow rate, application, and end use.

• Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Hardware

    • Portable Blood/ IV fluid warmers

    • Non-portable Blood/ IV Warmers

  • Consumables

• Flow Rate Outlook (Revenue, USD Million, 2021 - 2033)

  • Rapid/Fast Flow Warmers

  • Routine/Standard Flow Warmers

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Surgery

  • Pediatrics

  • Acute Care

  • Homecare

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals/Clinic

  • Ambulatory Services

  • Defense Forces

  • Rescue Forces